No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
EWTX Edgewise Therapeutics
- 30.780
- -0.020-0.06%
Close Dec 20 16:00 ET
- 30.780
- 0.0000.00%
Post 16:11 ET
2.91BMarket Cap-20.52P/E (TTM)
32.610High30.060Low1.11MVolume30.540Open30.800Pre Close34.71MTurnover1.89%Turnover RatioLossP/E (Static)94.69MShares38.12052wk High5.96P/B1.81BFloat Cap9.00052wk Low--Dividend TTM58.85MShs Float40.490Historical High--Div YieldTTM8.28%Amplitude5.120Historical Low31.255Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Edgewise Therapeutics Is Maintained at Outperform by Evercore ISI Group
Edgewise Therapeutics Analyst Ratings
Evercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $50
EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study
A Quick Look at Today's Ratings for Edgewise Therapeutics(EWTX.US), With a Forecast Between $50 to $50
Promising Outlook for Edgewise Therapeutics: Buy Rating Reaffirmed With Increased Price Target
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock the Full List